Brief report| Volume 33, ISSUE 4, P302-303, February 15, 1993

Download started.


Should DSM-III-R GAD criteria be used for studies of anxiolytics?

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Breier A.
        • Charney D.S.
        • Heninger G.R.
        The diagnostic of anxiety validity disorders and their relationship to depresive illness.
        Am J Psychiatry. 1985; 142: 787-797
        • Cerny J.A.
        • Himadi W.G.
        • Barlow D.H.
        Issues in diagnosing anxiety disorders.
        J Behav Assess. 1984; 6: 301-329
        • Commissaris R.L.
        • McCloskey T.C.
        • Harrington G.M.
        • Altman H.J.
        MR/Har and MNRA/Har Maudsley rat strains: Differential response to chlordiazepoxide in a conflict task.
        Pharmacol Biochem Behav. 1989; 32: 801-805
        • Crawley J.N.
        • Ninan P.T.
        • Pickar D.
        • et al.
        Neuropharmacological antagonism of the B-carboline-induced “anxiety” response in rhesus monkeys.
        J Neurosci. 1985; 5: 477-485
        • deRueter C.
        • Ruken H.
        • Garssen B.
        • et al.
        Comorbidity among the anxiety disorders.
        J Anxiety Disord. 1989; 3: 57-68
        • Fontana D.J.
        • McCloskey T.C.
        • Jolly S.K.
        • Commissaris R.L.
        The effects of beta-antagonists and anxiolytics on conflict behavior in the rat.
        Pharmacol Biochem Behav. 1989; 32: 807-813
        • Goldberg H.L.
        • Finnerty R.J.
        The comparative efficacy of buspirone and diazepam in the treatment of anxiety.
        Am J Psychiatry. 1979; 136: 1184-1187
        • Greenblatt D.J.
        • Shader R.I.
        Benzodiazepines in Clinical Practice.
        Raven Press, New York1974
        • Harris J.C.
        Experimental animal modeling of depression and anxiety.
        Psychiat Clin North Am. 1989; 12: 815-836
        • Rickels K.
        • Weisman K.
        • Norstad N.
        • et al.
        Buspirone and diazepam in anxiety: A controlled study.
        J Clin Psychiatry. 1982; 43: 81-86
        • Sanderson W.C.
        • Barlow D.H.
        A description of patients diagnosed with DSM-III-R generalized anxiety disorder.
        J Nerv Ment Dis. 1990; 178: 588-591
        • Snaith R.P.
        • Baugh S.J.
        • Clayden A.D.
        • et al.
        The Clinical Anxiety Scale: An instrument derived from the Hamilton Anxiety Scale.
        Br J Psychiatry. 1982; 141: 518-523
        • Task Force on DSM-IV
        DSM-IV Options Book: Work in Progress (7/1/91).
        American Psychiatric Association, Washington, DC1991
        • Weissman M.M.
        Panic and generalized anxiety: Are they separate disorders?.
        J Psychiatr Res. 1990; 24: 157-162
        • Weissman M.M.
        • Merikangas K.R.
        The epidemiology of anxiety and panic disorders: An update.
        J Clin Psychiatry. 1986; 47 (suppl): 11-17
        • Wheatley D.
        Buspirone: Multicenter efficacy study.
        J Clin Psychiatry. 1982; 43: 92-94